Lantern Pharma Inc. — Form D

Lantern Pharma Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-18. The offering totals $6.3M, of which $2.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-03-18
• Form: D
• Accession: 0001763950-19-000004
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $6.3M
• Amount sold: $2.4M
• Remaining: $3.9M
• Investors: 5
• Date of first sale: 2019-03-07
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-335101

Issuer

• Name: Lantern Pharma Inc.
• CIK: 0001763950
• Entity type: Corporation
• Jurisdiction: TEXAS
• Address: 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
• Phone: (972) 277-1136

Officers, directors & promoters (15)

Other filings by this issuer (2)

More

• CIK 1763950 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search